140 related articles for article (PubMed ID: 34030100)
1. Cytotoxic profile of CD3+CD20+ T cells in progressive multiple sclerosis.
Boldrini VO; Quintiliano RPS; Silva LS; Damasceno A; Santos LMB; Farias AS
Mult Scler Relat Disord; 2021 Jul; 52():103013. PubMed ID: 34030100
[TBL] [Abstract][Full Text] [Related]
2. Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.
Gingele S; Jacobus TL; Konen FF; Hümmert MW; Sühs KW; Schwenkenbecher P; Ahlbrecht J; Möhn N; Müschen LH; Bönig L; Alvermann S; Schmidt RE; Stangel M; Jacobs R; Skripuletz T
Cells; 2018 Dec; 8(1):. PubMed ID: 30597851
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.
von Essen MR; Ammitzbøll C; Hansen RH; Petersen ERS; McWilliam O; Marquart HV; Damm P; Sellebjerg F
Brain; 2019 Jan; 142(1):120-132. PubMed ID: 30561509
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
Shinoda K; Li R; Rezk A; Mexhitaj I; Patterson KR; Kakara M; Zuroff L; Bennett JL; von Büdingen HC; Carruthers R; Edwards KR; Fallis R; Giacomini PS; Greenberg BM; Hafler DA; Ionete C; Kaunzner UW; Lock CB; Longbrake EE; Pardo G; Piehl F; Weber MS; Ziemssen T; Jacobs D; Gelfand JM; Cross AH; Cameron B; Musch B; Winger RC; Jia X; Harp CT; Herman A; Bar-Or A
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2207291120. PubMed ID: 36634138
[TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
[TBL] [Abstract][Full Text] [Related]
6. Features of Human CD3+CD20+ T Cells.
Schuh E; Berer K; Mulazzani M; Feil K; Meinl I; Lahm H; Krane M; Lange R; Pfannes K; Subklewe M; Gürkov R; Bradl M; Hohlfeld R; Kümpfel T; Meinl E; Krumbholz M
J Immunol; 2016 Aug; 197(4):1111-7. PubMed ID: 27412413
[TBL] [Abstract][Full Text] [Related]
7. White matter lesions in multiple sclerosis are enriched for CD20
Hsiao CC; Fransen NL; van den Bosch AMR; Brandwijk KIM; Huitinga I; Hamann J; Smolders J
Eur J Immunol; 2021 Feb; 51(2):483-486. PubMed ID: 32949467
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD20 therapy depletes activated myelin-specific CD8
Sabatino JJ; Wilson MR; Calabresi PA; Hauser SL; Schneck JP; Zamvil SS
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25800-25807. PubMed ID: 31748274
[TBL] [Abstract][Full Text] [Related]
9. Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis.
Bar-Or A; O'Brien SM; Sweeney ML; Fox EJ; Cohen JA
CNS Drugs; 2021 Sep; 35(9):985-997. PubMed ID: 34370283
[TBL] [Abstract][Full Text] [Related]
10. CD20
Lee AYS
Inflamm Res; 2022 Nov; 71(10-11):1181-1189. PubMed ID: 35951029
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD8+CD56-perforin+ T cells are increased in multiple sclerosis patients.
Giovanni F; Domenico P; Alessandro M; Raffaele I; Viviana N; Katia PA; Paola BA
J Neuroimmunol; 2011 Dec; 240-241():137-41. PubMed ID: 22001684
[TBL] [Abstract][Full Text] [Related]
12. Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.
Zhu F; Shah N; Xu H; Schneider D; Orentas R; Dropulic B; Hari P; Keever-Taylor CA
Cytotherapy; 2018 Mar; 20(3):394-406. PubMed ID: 29287970
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal CD8
von Essen MR; Talbot J; Hansen RHH; Chow HH; Lundell H; Siebner HR; Sellebjerg F
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37369602
[TBL] [Abstract][Full Text] [Related]
14. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
[TBL] [Abstract][Full Text] [Related]
15. Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.
Andersson J; Samarina A; Fink J; Rahman S; Grundström S
Infect Immun; 2007 Nov; 75(11):5210-22. PubMed ID: 17664265
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis.
Müller-Ladner U; Kriegsmann J; Tschopp J; Gay RE; Gay S
Arthritis Rheum; 1995 Apr; 38(4):477-84. PubMed ID: 7536415
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis.
Sellebjerg F; Blinkenberg M; Sorensen PS
CNS Drugs; 2020 Mar; 34(3):269-280. PubMed ID: 31994023
[TBL] [Abstract][Full Text] [Related]
18. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
[TBL] [Abstract][Full Text] [Related]
19. Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives.
D'Amico E; Zanghì A; Gastaldi M; Patti F; Zappia M; Franciotta D
Autoimmun Rev; 2019 Jul; 18(7):665-672. PubMed ID: 31059839
[TBL] [Abstract][Full Text] [Related]
20. Absence of cytotoxic molecules in CD8- and/or CD56-positive adult T-cell leukaemia/lymphoma.
Ohshima K; Haraoka S; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):101-4. PubMed ID: 10599307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
